Drugs for Autoimmune Disease Flashcards
What are the “Mab” (monoclonal antibody) and “Cept” (fusion) drugs on our list?
“Mab”s: infliximab (Remicaid), adalimumab (Humira), tocilizumab (Actemra), rituximab (Rituxan)
“Cept”s: etanercept (Enbrel), abatacept (Orencia)
What are some common side effects of biologics?
Activation of latent TB (test for and treat TB first)
Opportunistic infections
Lymphomas
Infection site reactions
What are the indications for Etanercept?
Rheumatic syndromes: decreases new erosions in joints
What is the MOA of etanercept?
Fusion protein: fusion of TNF alpha receptor and Fc domain of IgG1
Acts as a decoy receptor for TNF alpha so it cannot do its work
What is the ADME for etanercept?
Administered SC q 2 weeks
often combined with non-biologic DMARDS
What are the side effects of etanercept?
increased antinuclear antibodies in 98% (can lead to SLE)
- activation of latent TB*
- opportunistic infections*
- lymphoma*
- infection site reactions*
- NOTE: less immunogenic (patients less likely to develop antibodies to etanercept than other TNF alpha blockers)*
What are the indications for infliximab and adalimumab?
RA
Ulcerative Colitis
Crohn’s Disease
What is the MOA of infliximab and adalimumab?
Which is chimeric human/mouse?
Monoclonal antibodies that bind TNF alpha and down regulate T-cells and macrophages
Infliximab is chimeric human/mouse
Adalimumab is all human
What is the ADME for infliximab (Remicaid)?
Administation: IV q 8 wks, often in combo with nonbiologic DMARDS
Patients often develop antibodies to Infliximab.
Coadministation with methotrexate prevents this.
What are the side effects of infliximab?
Basal cell and squamous cell skin cancer
Nausea, HA, sinusitis, rash, cough
- Injection site reaction*
- Activation of latent TB*
- Opportunistic infections*
- Lymphomas*
What are the side effects of adalimumab (Humira)?
Basal and squamous skin cancer
Lupus-like Sx (rare)
- TB activation*
- Lymphoma*
- Infection site reaction*
What is the MOA of Tocilizumab?
Monoclonal antibody
that inhibits binding of IL-6 to its receptor
thereby blocking activation of JAK-STAT pathway,
decreasing transcription of pro-inflammatory proteins
What are the indications for tocilizumab?
RA patients who are unresponsive to TNF alpha inhibitors
What is the ADME for tocilizumab?
Administration: IV q 4-6 weeks
How does Tocilizumab affect the metabolism of other medications?
IL-6 suppresses several CYPs in the liver,
so inhibition of IL-6 results in induction of CYPs
and increased metabolism of medications.
Increase dosages accordingly.